Abstract
Ischemic stroke (IS) is a highly heritable trait. Genome-wide association studies have identified several commonly occurring susceptibility risk loci for this condition. However, there are limited data on the contribution of rare genetic variation to IS. We conducted a whole-exome association study of IS in 152,058 UK Biobank participants (mean age 57, 6.8 [SD 8.0], 83,131 [54.7%] were females), including 1,777 IS cases (mean age 61.4 [SD 6.6], 666 [37.5%] were females). We performed single-variant analyses for all variants and gene-based analyses for loss of function and deleterious missense rare variants. In the gene-based analysis, rare genetic variation at CYP2R1 was significantly associated with IS risk (P=2.6×10−6), exceeding the Bonferroni-corrected threshold for 16,074 tests (P<3.1 × 10−6). We first replicated these findings using summary statistics from a genome-wide association study that included 67,162 IS cases and 454,450 controls (gene-based test for CYP2R1, P=0.003). We pursued a second replication focused on IS recurrence using individual-level data from 1,706 IS survivors, including 142 cases of recurrent IS, enrolled in the VISP trial (gene-based test for CYP2R1, P=0.001). We also found that common genetic variation at CYP2R1 was associated with white matter hyperintensity volume (42,310 participants) and both mean diffusivity and fractional anisotropy (17,663 participants) in the subcohort of UK Biobank (all gene-based tests P<0.05). Because CYP2R1 plays an important role in vitamin D metabolism, our results support a role of this pathway in the occurrence of ischemic cerebrovascular disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
JNA is supported by the American Heart Association Bugher Research Fellowship. GJF is supported by the National Institutes of Health (K76AG059992, R03NS112859 and P30AG021342), the American Heart Association (18IDDG34280056, 817874), the Yale Pepper Scholar Award (P30AG021342) and the Neurocritical Care Society Research Fellowship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UK Biobank has approval from the North West Multi-centre Research Ethics Committee (MREC) as a Research Tissue Bank (RTB) approval. This study was conducted using the UK Biobank resource under an approved data request (ref: 29900).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵# Jointly supervised this work
Data Availability
Genotype and phenotype data from UK Biobank (www.ukbiobank.ac.uk) and GARNET (https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000343.v4.p1) cannot be shared publicly because only approved users can have access. GWAS summary data used in this study are publicly accessible (https://www.kp4cd.org/dataset_downloads/stroke).
Abbreviations
- IS
- ischemic stroke
- GWAS
- genome wide association study
- WES
- whole exome sequencing
- KING
- kinship coefficient score
- LD
- linkage disequilibrium
- MAC
- minor allele count
- MAF
- minor allele frequencies
- LoF
- loss of function
- Dmis
- deleterious missense
- SVS
- small vessel stroke
- TOPMed
- Trans-Omics Precision Medicine
- dbGaP
- database of Genotypes and Phenotypes
- GARNET
- Genomics and Randomized Trials Network
- VISP
- Vitamin Intervention for Stroke Prevention
